• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Sickle cell trait not linked to increased risk of ischemic stroke

byJames EnglandandAndrew Cheung, MD MBA
April 27, 2018
in Cardiology, Chronic Disease, Emergency, Imaging and Intervention, Neurology, Pediatrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this meta-analysis of prospective population-based studies, sickle cell trait (SCT) was not associated with any difference in risk of first ischemic stroke.

2. After adjusting for known ischemic stroke risk factors, the presence of SCT was still not linked to any different risk of ischemic stroke.

Evidence Rating Level: 2 (Good)          

Study Rundown: Sickle cell disease is a genetic disorder caused by the presence of a homozygous mutation in the beta-globin gene and results in hemolysis and increased risk of thrombotic events. The heterozygous presence of the mutation results in SCT, and is prevalent in approximately 8% of the African-American patients. SCT is linked to increased risk of venous thromboembolic events, and is hypothesized to in part explain the increased risk of ischemic stroke in African-Americans as compared to non-hispanic white patients. The current study analysed the results of four large, prospective, population-based studies of incident ischemic stroke which included African-American participants and had genetic data available to ascertain SCT status. The analysis found that SCT did not result in any different risk for first-time stroke, and this result did not change when accounting for known vascular risk factors or genotyping data.

The results of the study provide evidence against the hypothesis that SCT may explain the difference in ischemic stroke risk between African-American and white populations. Further studies are needed to help understand the increased risk of stroke in this population. Patients with SCT with stroke should undergo full work up for underlying causes of stroke not related to their SCT. The major strengths of the study include the large population of prospectively studied patients with well documented vascular risk factors. The major limitations of the study include the lack of data on ischemic stroke subtype– associations with SCT and specific subtypes of ischemic stroke could not be evaluated.

Click to read the study, published in JAMA Neurology

RELATED REPORTS

Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation

Impaired lipoprotein cholesterol ratio is associated with cognitive impairment in patients with stroke

Delayed alteplase has clinical benefits in posterior circulation stroke outcomes

Relevant Reading: Sickle Cell Trait and Cognitive Function in African Americans: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort

In-Depth [meta-analysis]: The study is a meta-analysis of four large, prospective studies which included African-American patients: the Jackson Heart Study, Multi-Ethnic Study of Atherosclerosis, Reasons for Geographic and Racial Differences in Stroke, and Women’s Health Initiative. Participants were included in the meta-analysis if they had no missing covariate data, and were not homozygous for the sickle cell mutation, or compound heterozygous (such as with HbSC disease). Patients were assessed at baseline and then annually or semi-annually with stroke incidence determined by hospitalizations, self-reports, and supportive radiographic evidence. SCT was determined using direct genotyping with PCR, or whole-exome sequencing and imputation.

The study included 19 464 African-American patients including 1520 with SCT. The rates of ischemic stroke were not different between those with SCT (2.9 per 1000 person-years) or without SCT (3.2 per 1000 person-years). The hazard ratio for risk of ischemic stroke for patients with SCT compared to those without was not significant (HR, 0.80; 95% CI, 0.47-1.35; p = 0.82). The analysis was consistent after adjusting for vascular risk factors, and genotype data.

Image: CC/Wiki

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: ischemic strokesickle cell anemia
Previous Post

Systematic crosschecking between emergency physicians may decrease adverse events

Next Post

2 Minute Medicine Rewind April 30, 2018

RelatedReports

Atrial fibrillation-specific management increases days alive and out of hospital
Cardiology

Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation

July 4, 2025
Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Chronic Disease

Impaired lipoprotein cholesterol ratio is associated with cognitive impairment in patients with stroke

June 4, 2025
Stroke expansion following intra-arterial therapy may explain worse outcomes
Emergency

Delayed alteplase has clinical benefits in posterior circulation stroke outcomes

May 30, 2025
Use of aspirin for primary prevention linked to increased risk of intracranial hemorrhage
Cardiology

Direct oral anticoagulants increase bleeding risk after intracerebral hemorrhage in patients with atrial fibrillation

May 2, 2025
Next Post
Intensive rehabilitation not superior to traditional therapy for arm function after stroke

2 Minute Medicine Rewind April 30, 2018

Maternal vaccination during pregnancy not associated with infant hospitalization, mortality

In-utero exposure to tenofovir-emtricitabine not associated with higher risk of adverse birth outcomes

Treatment of subclinical hypothyroidism ineffective in older adults

EXTEND-IA TNK: Tenecteplase is superior to alteplase as neoadjuvant treatment for mechanical thrombectomy

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
  • Mazdutide significantly reduces weight in adults with overweight or obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.